Short Squeeze Stocks: BBBY, SI and 3 Other Stocks Ready to Squeeze


  • Short squeeze stocks are in vogue lately, as the banking crisis has pushed some investors toward the bears.
  • Companies like Bed Bath & Beyond (BBBY) are seemingly perpetually buried under short investments.
  • What short squeeze candidates should you keep an eye on as the S&P 500’s future remains precarious?
Magnifying lens over background with text Short squeeze, with the financial data visible in the background. 3D rendering., ATER is experiencing a short squeeze
Source: g0d4ather /

Short squeeze stocks are the talk of Wall Street at the moment. As the banking crisis continues to unfold, some investors are seeking refuge by betting against many well-known losers — and reaping tremendous gains.

Indeed, the short interest — or the number of shares sold short relative to the wider stock base — on a number of well-known companies has risen rapidly. Reasonably so, at a time when the winners are struggling to turn a windfall and losers are struggling to stay listed, it should be a no brainer that investors are choosing the latter.

So, which short squeeze stocks have been taking off lately?

5 Short Squeeze Stocks Wall Street Can’t Get Enough Of

  1. Bed Bath and Beyond (NASDAQ:BBBY) sits at the top of the list, likely to no surprise. The company has long been a short seller favorite. Bed Bath has been on a downward trajectory for the better part of the last decade and recently, its short interest has skyrocketed. Currently, the struggling retailer has a short interest of 72.23%. That said, last month BBBY managed to raise $1 billion in an effort to fend off bankruptcy.
  2. Next up is Silvergate Capital (NYSE:SI). Silvergate has lost almost 90% of its value since the start of the year, leaving traditional investors in the dust. Currently, the California-based regional bank has a short interest of 71.64%.
  3. Design Therapeutics (NASDAQ:DSGN) is third on the list, with a short interest of 41.23%. While not as infamous as short squeeze stocks like Silvergate or Bed Bath, the biopharmaceutical company has certainly earned its spot on the list. DSGN stock is down more than 40% year-to-date (YTD).
  4. Novavax (NASDAQ:NVAX) lands in fourth place on the list. The biotech company was once a forerunner in the Covid-19 vaccine race. Unfortunately, though, its business has largely fallen by the wayside. NVAX has a short interest of 38.70%.
  5. Last up on this list is plant-based food company Tattooed Chef (NASDAQ:TTCF), the only name on this list that’s up on the year. Currently, shares are up about 4% YTD. Despite this, TTCF has a notable short interest of 35.04%, likely attributable to its most recent earnings miss of -46 cents per share.

On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that’s writers disclose this fact and warn readers of the risks.

Read More:Penny Stocks — How to Profit Without Getting Scammed

On the date of publication, Shrey Dua did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines.

With degrees in economics and journalism, Shrey Dua leverages his ample experience in media and reporting to contribute well-informed articles covering everything from financial regulation and the electric vehicle industry to the housing market and monetary policy. Shrey’s articles have featured in the likes of Morning Brew, Real Clear Markets, the Downline Podcast, and more.

Article printed from InvestorPlace Media,

©2024 InvestorPlace Media, LLC